World Health Organization approved SK bioscience as supplier of Novavax Nuvaxovid COVID-19 vaccine
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
-
-
Novavax Nuvaxovid COVID-19 vaccine recommended by CHMP for expanded conditional Marketing Authorization in EU as booster for adults
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
-
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
-
$838 Million neurosciences center broke ground in Connecticut
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
-
U.S. Department of Health and Human Services funded U.S.-based production of Smallpox and Mpox vaccine
On Aug. 29, 2022, the U.S. Department of Health and Human Services (HHS) announced it had provided approximately…
-
Novavax Nuvaxovid COVID-19 vaccine granted expanded conditional marketing authorization in UK for use in adolescents aged 12 through 17
On Aug. 26, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
-
Pfizer and BioNTech completed submission to EMA for Omicron BA.4/BA.5 adapted bivalent vaccine
On Aug. 26, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
-
First gene therapy for adults with severe hemophilia A, BioMarin’s ROCTAVIAN, approved by EC
On Aug. 24, 2022, BioMarin Pharmaceutical announced that the European Commission (EC) has granted conditional marketing authorization (CMA)…
-
Pfizer and BioNTech announced updated COVID-19 vaccine data supporting efficacy in children 6 months through 4 years of age
On Aug. 23, 2022, Pfizer and BioNTech announced updated efficacy results from a Phase 2/3 trial evaluating a…
-
Democratic Republic of the Congo declared Ebola resurgence in North Kivu
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
-
Moderna announced supplying 12 million doses of Omicron-containing bivalent COVID-19 booster vaccines to Government of Canada
On Aug. 23, 2022, Moderna announced they will supply 12 million doses of its COVID-19 shot adapted to…
-
Pfizer and BioNTech submitted application to U.S. FDA for EUA of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine
On Aug. 22, 2022, Pfizer and BioNTech announced they had completed a submission to the U.S. Food and…
-
Moderna completed application to U.S. FDA for EUA of omicron-targeting bivalent Covid-19 booster vaccine
On Aug. 22, 2022, Moderna announced it has applied for an U.S. Food and Drug Administration (FDA) emergency…
-
U.S. FDA granted EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents Aged 12 through 17
On Aug. 19, 2022, Novavax announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received expanded emergency use…
-
Novavax Nuvaxovid COVID-19 vaccine granted expanded provisional approval in New Zealand for adolescents aged 12 through 17
On Aug. 18, 2022, Novavax announced that New Zealand’s Medsafe had granted expanded provisional approval for Nuvaxovid (NVX-CoV2373)…
-
Biotechnology | Infectious Disease | NIH | U.S. Congress | USDA | Vaccine
The White House announced actions to combat Mpox outbreak
On Aug. 18, 2022, the White House announced that the U.S. Department of Health and Human Services (HHS)…
-
FDA approved first cell Based gene therapy to treat adult and pediatric patients with Beta-thalassemia
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
-
Biotechnology | Vaccine | WHO
GSK awarded $170 million UNICEF contract for malaria vaccine
On Aug. 16, 2022, UNICEF announced that it had awarded a contract for the first ever supply of…
-
Medicines and Healthcare Products Regulatory Agency authorized Moderna’s Omicron-containing bivalent booster in the UK
On Aug. 15, 2022, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK…
-
Roche launched new diagnostic test for the better understanding of immune response to SARS-CoV-2
On Aug. 15, 2022, Roche announced the launch of the Elecsys IGRA SARS-CoV-2 test in countries that accept…
-
Biotechnology | FDA | Infectious Disease | NIH | Therapeutics | Vaccine
U.S. Department of Health and Human Services made more vaccine doses available to support Mpox response
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
-
WHO experts gave Mpox virus variants new names
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
-
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea for use in adolescents aged 12 through 17
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…
-
Roche announced U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
On Aug. 11, 2022, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
FDA authorized Emergency Use of JYNNEOS Mpox vaccine
On Aug. 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the…
-
NIH first to develop 3D structure of twinkle protein
On Aug. 5, 2022, researchers from the National Institutes of Health announced that they had developed a three-dimensional…
-
Agriculture | Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
CDC confirmed first human infection with flu virus from pigs during 2022
On Aug. 5, 2022, the Centers for Disease Control and Prevention (CDC) has reported the first human infection…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
-
Novavax announced initiation of phase 2b/3 Hummingbird global clinical trial for COVID-19 vaccine in children aged six months through 11 years
On Aug. 4, 2022, Novavax announced the initiation of its Phase 2b/3 Hummingbird global clinical trial. The trial…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | U.S. Congress | Vaccine
U.S. Department of Health and Human Services declared Mpox a public health emergency
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
